• 1
    Gordon DJ, Probstfield JL, Garrison RJ, et al. High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. Circulation. 1989;79:815.
  • 2
    Kannel WB, Castelli WP, Gordon T, et al. Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study. Ann Intern Med. 1971;74:112.
  • 3
    Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: a population-based ultrasonography study. Atherosclerosis. 1990;81:3340.
  • 4
    Salonen R, Salonen JT. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med. 1991;229:225231.
  • 5
    Prati P, Vanuzzo D, Casaroli M, et al. Prevalence and determinants of carotid atherosclerosis in a general population. Stroke. 1992;23:17051711.
  • 6
    Lassila HC, Tyrrell KS, Matthews KA, et al. Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women. Stroke. 1997;28:513517.
  • 7
    Uurtuya S, Kotani K, Yoshioka H, et al. Determinants of carotid atherosclerosis in the general Mongolian population. Ethn Dis. 2010;20:257260.
  • 8
    Klag MJ, Ford DE, Mead LA, et al. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;328:313318.
  • 9
    Li S, Chen W, Srinivasan SR, et al. Childhood cardiovascular risk factors and carotid vascular changes in adulthood: the Bogalusa Heart Study. JAMA. 2003;290:22712276.
  • 10
    Raitakari OT, Juonala M, Kahonen M, et al. Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. JAMA. 2003;290:22772283.
  • 11
    Arsenault BJ, Rana JS, Stroes ES, et al. Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol. 2009;55:3541.
  • 12
    Tamada M, Makita S, Abiko A, et al. Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio as a useful marker for early-stage carotid atherosclerosis. Metabolism. 2010;59:653657.
  • 13
    Cui Y, Blumenthal RS, Flaws JA, et al. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med. 2001;161:14131419.
  • 14
    O'Leary DH, Polak JF. Intima-media thickness: a tool for atherosclerosis imaging and event prediction. Am J Cardiol. 2002;90:18L21L.
  • 15
    Crouse JR. B-mode ultrasound in clinical trials. Answers and questions. Circulation. 1993;88:319321.
  • 16
    Blankenhorn DH, Seltzer RH, Crawford DW, et al. Beneficial effects of colestipol-niacin therapy on the common carotid artery. Two- and four-year reduction of intima-media thickness measured by ultrasound. Circulation. 1993;88:2228.
  • 17
    Wiklund O, Hulthe J, Wikstrand J, et al. Effect of controlled release/extended release metoprolol on carotid intima-media thickness in patients with hypercholesterolemia: a 3-year randomized trial Stroke. 2002;33:572577.
  • 18
    O'Leary DH, Polak JF, Kronmal RA, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999;340:1422.
  • 19
    van der Meer IM, Bots ML, Hofman A, et al. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation. 2004;109:10891094.
  • 20
    Xie WX, Liang LR, Zhao LC, et al. Combination of carotid intima-media thickness and plaque for better predicting risk of ischaemic cardiovascular events. Heart. 2011;97:13261331.
  • 21
    Greenland P, Abrams J, Aurigemma GP, et al. Prevention Conference V: Beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101:E16E22.
  • 22
    People's Republic of China-United States Cardiovascular and Cardiopulmonary Epidemiology Research Group. An epidemiological study of cardiovascular and cardiopulmonary disease risk factors in four populations in the People' s Republic of China: Baseline report from the P.R.C.-U.S.A. Collaborative Study. Circulation. 1992;85:10831096.
  • 23
    Xie GQ, Li Y, Shi P, et al. Baseline pulmonary function and quality of life 9 years later in a middle-aged Chinese population. Chest. 2005;128:24482457.
  • 24
    Liang LR, Wong ND, Shi P, et al. Cross-sectional and longitudinal association of cigarette smoking with carotid atherosclerosis in Chinese adults. Prev Med. 2009;49:6267.
  • 25
    Lu M, Wu L, Shi P, et al. Hypertension and subclinical carotid atherosclerosis in a suburban general population in China. J Hypertens. 2004;22:16991706.
  • 26
    Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499502.
  • 27
    Myers GL, Cooper GR, Winn CL. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements. Clin Lab Med. 1989;9:105135.
  • 28
    Nieto FJ, Diez-Roux A, Szklo M, et al. Short- and long-term prediction of clinical and subclinical atherosclerosis by traditional risk factors. J Clin Epidemiol. 1999;52:559567.
  • 29
    D'Agostino RB, Russell MW, Huse DM, et al. Primary and subsequent coronary risk appraisal: new results from the Framingham study. Am Heart J. 2000;139:272281.
  • 30
    Pencina MJ, D'Agostino RB, Larson MG, et al. Predicting the 30-year risk of cardiovascular disease: the Framingham heart study. Circulation. 2009;119:30783084.
  • 31
    Wilson PW, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:18371847.
  • 32
    Joint Committee for Developing Chinese Guidelines on Prevention and Treatment of Dyslipidemia in Adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults [in Chinese]. Chin J Cardiol. 2007;35:390419.
  • 33
    Catapano AL, Reiner Z, De Backer G, et al; ESC Committee for Practice Guidelines 2008–2010 and 2010–2012 Committees. ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217:S1S44.
  • 34
    Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227239.
  • 35
    Pischon T, Girman CJ, Sacks FM, et al. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005;112:33753383.
  • 36
    Lemieux I, Lamarche B, Couillard C, et al. Total cholesterol/HDL cholesterol ratio vs LDL cholesterol/HDL cholesterol ratio as indices of ischemic heart disease risk in men: the Quebec Cardiovascular Study. Arch Intern Med. 2001;161: 26852692.
  • 37
    Miller M, Seidler A, Kwiterovich PO, et al. Long-term predictors of subsequent cardiovascular events with coronary artery disease and ‘desirable’ levels of plasma total cholesterol. Circulation. 1992;86:11651170.
  • 38
    Kanters SD, Algra A, van Leeuwen MS, et al. Reproducibility of in vivo carotid intima-media thickness measurements: a review. Stroke. 1997;28:665671.